A retrospective study assessing the clinical outcomes and costs of acute hepatitis A in Cape Town, South Africa.

ABSTRACT:

Background

While some evidence has been demonstrated the cost-effectiveness of routine hepatitis A vaccination in middle-income countries, the evidence is still limited in other settings including in South Africa. Given this, the evidence base around the cost of care for hepatitis A needs to be developed towards considerations of introducing hepatitis A vaccines in the national immunisation schedule and guidelines.

Objectives

To describe the severity, clinical outcomes, and cost of hepatitis A cases presenting to two tertiary healthcare centers in Cape Town, South Africa.

Methods

We conducted a retrospective folder review of patients presenting with hepatitis A at two tertiary level hospitals providing care for urban communities of metropolitan Cape Town, South Africa

SUBMITTER: Patterson J 

PROVIDER: S-EPMC8751253 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature